B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

NPSR1

MOLECULAR TARGET

neuropeptide S receptor 1

UniProt: Q6W5P4NCBI Gene: 38712919 compounds

NPSR1 (neuropeptide S receptor 1) is targeted by 19 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting NPSR1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Calcimycin1.614
2Clotrimazole1.102
3Fluspirilene1.102
4Loratadine1.102
5Apigenin 5,7,4'-trihydroxy-flavone,0.691
6Methylene Blue0.691
717 alpha-Hydroxyprogesterone Caproate Hydroxyprogesterone derivative that acts as0.691
8Chlormadinone Acetate0.691
9Cinnarizine0.691
10daph0.691
11Ezetimibe0.691
12gedunin0.691
13Medroxyprogesterone Acetate0.691
14Megestrol Acetate Megestrol acetate is0.691
15Misoprostol0.691
16Nicardipine0.691
17Ritonavir0.691
18Thioridazine0.691
19urolithin b0.691

About NPSR1 as a Drug Target

NPSR1 (neuropeptide S receptor 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 19 compounds with documented NPSR1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

NPSR1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.